World Cancer Day highlights the shared impact of cancer and the importance of staying engaged and connected across the cancer ...
Indigenous perspectives and convenings, including the World Indigenous Cancer Conference, are highlighted as mechanisms to ...
After a brain cancer diagnosis, Dr. Bobby Mukkamala says becoming a patient highlighted care barriers, emotions and the need ...
World Cancer Day serves as a powerful reminder of the global impact of cancer and the shared responsibility to address it. In ...
Post-diagnosis risk assessment clarifies cancer etiology and germline contribution, shaping therapeutic planning, prevention ...
In closing, the panel of experienced multiple myeloma care partners offers a powerful, unified message of hope and actionable ...
Former U.S. goalkeeper opens up about a large B-cell lymphoma diagnosis and finally reaching remission after CAR T-cell therapy, urging patients to advocate and seek options. Former U.S. Men’s ...
Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...
The U.S. FDA has granted fast track status to pelareorep combination therapy for some KRAS-mutant, microsatellite-stable metastatic colorectal cancers.
A common care partner challenge is managing guilt when engaging in activities for personal wellness, especially if the multiple myeloma patient cannot participate.
The FDA granted Breakthrough Therapy status to zovegalisib plus Faslodex for patients with PIK3CA-mutated HR+/HER2- advanced breast cancer. The U.S. Food and Drug Administration (FDA) has granted ...
Former U.S. goalkeeper opens up about a large B-cell lymphoma diagnosis and finally reaching remission after CAR T-cell therapy, urging patients to advocate and seek options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results